Slideshow

Quiz: Drug-Induced Parkinsonism

Author(s):

Veronica Hackethal, MD

Does the atypical antipsychotic clozapine carry high risk for the development of drug-induced parkinsonism? What are DSM-5 criteria for the diagnosis of neuroleptic-induced parkinsonism? These questions and more in our quiz.

Related Videos
Cheryl Kyinn, PA-C
Sheryll Baltazar, NP-C
Sushma Kola, MD
Julie Pilitsis, MD, PhD, MBA
Clarisse Goas MSN, APRN-CNP
Related Content
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
Published: March 27th 2025 | Updated: March 28th 2025

FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome

Isabella Ciccone, MPH
Special Episode: What Apomorphine Infusion Approval Means for Parkinson Disease Care
March 27th 2025

Special Episode: What Apomorphine Infusion Approval Means for Parkinson Disease Care

Marco Meglio
This Week on NeurologyLive® — March 17, 2025
March 17th 2025

This Week on NeurologyLive® — March 17, 2025

NeurologyLive® Staff
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
January 10th 2025

Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test

Marco Meglio
Blueprints for Better Care: 2024 Neurology Guideline Highlights
March 12th 2025

Blueprints for Better Care: 2024 Neurology Guideline Highlights

Marco Meglio Isabella Ciccone, MPH
NeuroVoices: Tanya Simuni, MD, FAAN, on Using the Neuronal α-Synuclein Disease Integrated Staging System Framework to Advance Parkinson Disease Staging
March 12th 2025

NeuroVoices: Tanya Simuni, MD, FAAN, on Using the Neuronal α-Synuclein Disease Integrated Staging System Framework to Advance Parkinson Disease Staging

Isabella Ciccone, MPH Tanya Simuni, MD, FAAN
© 2025 MJH Life Sciences

All rights reserved.